MedTrace Logo

Dexamethasone in Tick-borne Encephalitis

NCT07584525 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-05-13

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.

Conditions

  • Tick-Borne Encephalitis

Interventions

DRUG

Dexametasone

dexamethasone 4 mg tid

DRUG

Saline (0.9% NaCl)

20 ml saline

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-03
Primary Completion
2030-09-30
Completion
2030-09-30

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07584525 on ClinicalTrials.gov